Ponatinib inhibits polyclonal drug-resistant KIT oncoproteins and shows therapeutic potential in heavily pretreated gastrointestinal stromal tumor (GIST) patients

author
created [InstanceEdit:9670329] Rothfels, Karen, 2019-12-09
dbId 9670319
displayName Ponatinib inhibits polyclonal drug-resistant KIT oncoproteins and shows therapeutic potential in heavily pretreated gastrointestinal stromal tumor (GIST) patients
journal Clin. Cancer Res.
pages 5745-5755
pubMedIdentifier 25239608
schemaClass LiteratureReference
title Ponatinib inhibits polyclonal drug-resistant KIT oncoproteins and shows therapeutic potential in heavily pretreated gastrointestinal stromal tumor (GIST) patients
url http://www.ncbi.nlm.nih.gov/pubmed/25239608
volume 20
year 2014
Cite Us!